14158 Results (Page 446 of 567)
All Market Research Reports
Saudi Arabia Neurology Clinical Trials Market Analysis
The Saudi Arabia Neurology Clinical Trials market is projected to grow from $88.9 Mn in 2022 to $152.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders, and increasing investment in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Tabuk Pharmaceuticals.
Philippines Neurology Clinical Trials Market Analysis
The Philippines Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $18.3 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the country's growing clinical trial industry and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Pfizer & Philippine Pharma Solutions, Inc.
Mexico Neurology Clinical Trials Market Analysis
The Mexico Neurology Clinical Trials market is projected to grow from $78.5 Mn in 2022 to $122.7 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses and increased investments in R&D by pharmaceutical companies. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Laboratorios Silanes.
Global Clinical Trial Patient Recruitment Services Market Analysis
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.
Japan Neurology Clinical Trials Market Analysis
The Japan Neurology Clinical Trials market is projected to grow from $325.1 Mn in 2022 to $518.1 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological diseases and a robust healthcare system. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, Eisai Co., Ltd & Daiichi Sankyo.
Italy Neurology Clinical Trials Market Analysis
The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.
Indonesia Neurology Clinical Trials Market Analysis
The Indonesia Neurology Clinical Trials market is projected to grow from $31.4 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising investments by global pharmaceutical companies in Indonesia due to reduced operating costs and improved healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Roche & PT Dexa Medica.
UK Alzheimer’s Disease Drugs Market Analysis
The UK Alzheimer’s disease drugs market was valued at $401 Mn in 2022 and is estimated to expand at a CAGR of 6.42% from 2022-30 and will reach $660 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Accord Healthcare, Aesica Queenborough, Allen & Hanburys, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
Germany Neurology Clinical Trials Market Analysis
The Germany Neurology Clinical Trials market is projected to grow from $191.4 Mn in 2022 to $256 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy and regulatory frameworks that encourage clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer & Bayer.
UAE Alzheimer’s Disease Drugs Market Analysis
UAE Alzheimer’s Disease Drugs market was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $158 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Julphar, Lundbeck, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, Roche, Merck & Co., Novartis, Pfizer, and Teva Pharmaceutical among others.
France Neurology Clinical Trials Market Analysis
The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.
Egypt Neurology Clinical Trials Market Analysis
The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.
China Neurology Clinical Trials Market Analysis
The China Neurology Clinical Trials market is projected to grow from $420.4 Mn in 2022 to $722.4 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the country's increasing incidence of neurological disorders and pharmaceutical firms boosting their investments in R&D. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Shanghai Green Valley Pharmaceuticals & Jiangsu Hengrui Medicine.
Brazil Neurology Clinical Trials Market Analysis
The Brazil Neurology Clinical Trials market is projected to grow from $130.8 Mn in 2022 to $216.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders and government initiatives to support clinical research in the country. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc & Aché Laboratórios Farmacêuticos S.A.
Australia Neurology Clinical Trials Market Analysis
The Australia Neurology Clinical Trials market is projected to grow from $62.8 Mn in 2022 to $107.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by internationally competitive government subsidies for R&D investment and a well-developed infrastructure to support clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc, Neuroscience Trials Australia & Prana Biotechnology Limited.
UK Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the UK infectious disease therapeutics market will reach a value of $3.75 Bn from $3.12 Bn in 2022, growing at a CAGR of 2.4% during 2022-2030. Infectious Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as GlaxoSmithKline, Faron Pharmaceuticals and Emergent BioSolutions. The infectious disease therapeutics market in the UK is segmented into different therapeutic areas and different treatment types. The major factors affecting the UK infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of the UK.
UAE Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the UAE infectious disease therapeutics market will reach a value of $909.4 Mn from $599.35 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030. The Infectious Disease Therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Medpharma, Julphar and Neopharma. The Infectious Disease Therapeutics market in UAE is segmented into different therapeutic areas and different diseases type. The major factors affecting the UAE infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various the areas of UAE.
Turkey Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey infectious disease therapeutics market will reach a value of $1400 Mn from $958.96 Mn in 2022, growing at a CAGR of 4.9% during 2022-2030. Infectious Disease Therapeutics in Turkey is dominated by a few domestic pharmaceutical companies such as Abdi İbrahim, Deva Holding and Nobel İlaç. The Infectious Disease Therapeutics market in Turkey is segmented into different therapeutic areas and different diseases type. The major factors affecting the Turkey infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Turkey.
India Alzheimer’s Disease Drugs Market Analysis
The India Alzheimer’s disease drugs market was valued at $280 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.42% from 2022 to 2030 and will reach $666 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Alkem Laboratories., Eli Lilly and Company, Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Pfizer.
Spain Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Spain infectious disease therapeutics market will reach a value of $3.01 Bn from $2.31 Bn in 2022, growing at a CAGR of 2.6% during 2022-2030. Infectious Disease Therapeutics in Spain is dominated by a few domestic pharmaceutical companies such as Grifols, AB-Biotics and Zendal. The Infectious Disease Therapeutics market in Spain is segmented into different therapeutic areas and different diseases type. The major factors affecting the Spain infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious diseases treatment in various of areas of Spain.
Global Alzheimer’s Disease Drugs Market Analysis
Global Alzheimer’s disease drugs market was valued at $15.42 Bn in 2022 and is estimated to expand at a CAGR of 8.42% from 2022-30 and will reach $29.44 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
South Africa Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the South Africa infectious disease therapeutics market will reach a value of $1203 Mn from $779.2 Mn in 2022, growing at a CAGR of 5.6% during 2022-2030. The Infectious Disease Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Biovac, Adcock Ingram and Aspen Pharmacare. The Infectious Disease Therapeutics market in South Africa is segmented into different therapeutic areas and different diseases type. The major factors affecting the South African infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of South Africa.
Italy Teleradiology Market Analysis
The Italy Teleradiology market size was valued at $57 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2030 and will reach $ 133 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Italy teleradiology market will grow due to advancements in technology, such as electronic medical records (EMRs) and picture archiving and communication systems (PACS), have made it easier to transmit and store medical images securely. The key market players are Telemedicina Italiana S.r.l., LaBS - Laboratorio di Bioingegneria e di Informatica Sanitaria, MEDICAIM S.r.l., Telerradiologia Italia S.r.l., Telerad Italia S.r.l., and others.
UAE Teleradiology Market Analysis
The UAE Teleradiology market size was valued at $12 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 12.7% from 2022 to 2030 and will reach $ 31 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. Teleradiology is becoming increasingly popular in UAE due to the growing demand for remote healthcare services, particularly in rural or underserved areas. The key market players are Nucleous Telemedicine LLC, Telemedicine.ae, GulfHealth, Advanced Radiology Centre, Global Diagnostics, Telemedico, Prime Diagnostic Centre, Alemadi Radiology, MediGence, TeleRad Providersand others.
Germany Teleradiology Market Analysis
The Germany Teleradiology market size was valued at $87 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030 and will reach $ 185 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Germany teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Radiology Consultants Associated (RCA), NightHawk Radiology Services, Calgary Scientific, and others.
